Death Doula for Primary Sclerosing Cholangitis (PSC): End-of-Life Support

The short answer: Primary sclerosing cholangitis (PSC) is a rare liver disease that causes progressive bile duct scarring and liver failure. With no FDA-approved treatment and significant cancer risk, PSC often leads to liver transplant or end-of-life care. A death doula supports patients through this difficult journey.

Primary Sclerosing Cholangitis at End of Life

Primary sclerosing cholangitis (PSC) is a rare, progressive liver disease characterized by inflammation and scarring of the bile ducts, causing cirrhosis and liver failure over time. PSC affects approximately 30,000 Americans and has no FDA-approved treatment that slows its progression. Liver transplantation is the only potentially curative treatment, but PSC recurs in approximately 25% of transplant recipients. PSC also carries a significantly elevated risk of cholangiocarcinoma (bile duct cancer) — a complication that significantly worsens prognosis.

The PSC End-of-Life Journey

PSC's end-of-life trajectory mirrors that of other forms of end-stage liver disease: progressive jaundice, recurrent cholangitis (bile duct infections), ascites, hepatic encephalopathy, and portal hypertension complications. The unpredictability of PSC — cholangitis episodes can cause rapid deterioration — makes advance care planning particularly important. Death doulas help PSC patients complete advance directives before cognitive decline from hepatic encephalopathy makes decision-making difficult.

Cholangitis Crises and Emergency Planning

Acute cholangitis — bacterial infection of the bile ducts — causes fever, right upper quadrant pain, and jaundice (Charcot's triad) and can be rapidly life-threatening. For PSC patients at end of life, the question of whether to pursue aggressive antibiotic treatment and biliary intervention for cholangitis versus comfort care is an important advance care planning discussion. Death doulas help families have this conversation before a cholangitis crisis forces an unplanned decision.

PSC and IBD: The Dual Diagnosis

Approximately 75% of PSC patients have co-occurring inflammatory bowel disease (IBD) — usually ulcerative colitis. Managing both conditions simultaneously, particularly at end of life, requires coordination between gastroenterology, hepatology, and palliative care. Death doulas help patients navigate the complexity of dual-diagnosis end-of-life care.

Frequently Asked Questions

Is PSC terminal?

PSC is a progressive liver disease without FDA-approved treatment that typically leads to liver failure over years. Liver transplant can extend life, but PSC recurs in approximately 25% of recipients. Without transplant, PSC is eventually terminal.

What complications of PSC are most serious at end of life?

Cholangiocarcinoma (bile duct cancer), recurrent cholangitis, hepatic encephalopathy, and portal hypertension complications (varices, ascites) are the most serious PSC complications. Each has specific palliative management considerations.

Does PSC qualify for hospice?

Yes — PSC with advanced liver failure, significant functional decline, and a prognosis of 6 months or less qualifies for hospice. Many PSC patients benefit from early hospice consultation given the disease's unpredictable acute episodes.

How is cholangitis managed at end of life?

At end of life, the decision about whether to treat acute cholangitis with antibiotics and biliary intervention (ERCP) versus comfort care is an important advance care planning conversation. This decision should be made in advance rather than during an acute episode.

Is there a PSC community for support?

Yes — the PSC Partners Seeking a Cure organization (pscpartners.org) provides patient and family support, education, and community. Death doulas can connect PSC patients and families with this organization as part of end-of-life support.

Renidy connects grieving families with compassionate death doulas and AI-powered funeral planning tools. Try our free AI funeral planner or find a death doula near you.